Patent ID: 9408886
Filing Date: 2016-08-09
CPC Classification: A61K,A61P,C07K,C12N

Claim Text:
1. A method for treating cancer comprising administering a Myristoylated Alanine-Rich C Kinase Substrate (MARCKS)-inhibitory peptide to a subject that has been diagnosed with cancer, in an effective amount to treat said cancer, wherein the peptide is selected from the group consisting of Ac-GAQFSKTAAK-OH (SEQ ID NO: 106), Ma-GAQFSKTAAK-OH (SEQ ID NO: 106), Ma-GAQFSKTAAK-NH2 (SEQ ID NO: 106), Ac-RGAQFSKTAAK-NH2 (SEQ ID NO: 234), Ac-GAQFSKTAA-OH (SEQ ID NO: 121), Ma-RGAQFSKTAA-NH2 (SEQ ID NO: 234), and Ma-AKGE-OH (SEQ ID NO: 219), wherein Ma is myristoyl and Ac is acetyl.